Objective: We previously demonstrated that high calcium diets inhibit obesity in both mice and humans; this effect is mediated, in part, by dietary calcium suppression of 1a, 25-dihydroxyvitamin D, which exerts both non-genomic and genomic effects on adipocyte metabolism. However, the presence of the nuclear vitamin D receptor (nVDR) and its role in this regulation in adipocytes have not been investigated.
Introduction
We previously demonstrated an anti-obesity effect of high calcium diets, which is attributable, in part, to the regulatory role of 1a, 25-dihydroxyvitamin D in adipocyte energy metabolism. [1] [2] [3] We have shown that 1a, 25-dihydroxyvitamin D mediates increases in intracellular calcium ([Ca 2 þ ]i) in adipocytes via the 1a, 25-dihydroxyvitamin D-membraneassociated rapid response steroid hormone (1, 25D 3 -MARRS) binding protein, stimulates lipogenesis and inhibit lipolysis via a calcium-dependent mechanism. 4, 5 We have also shown a dose-responsive inhibition of uncoupling protein 2 expression by 1a, 25-dihydroxyvitamin D in adipocytes; this is a genomic effect, presumably mediated by the nuclear vitamin D receptor (nVDR). 6 However, the presence of the nVDR in mature adipocytes and its role in adipocyte metabolism are not clear. Recent data from Hollenberg et al. 7 suggest that the nVDR is only transiently expressed during adipogenesis and thereafter remains at very low levels at mature adipocytes. However, whether nVDR can be regulated by 1a, 25-dihydroxyvitamin D in mature adipocytes is not yet clear. As cortisol is used in initiating the adipogenic program and our previous work demonstrated a role of 1a, 25-dihydroxyvitamin D in modulation of glucocorticoid production via nVDR in adipocytes, 8 we also evaluated the interaction between 1a, 25-dihydroxyvitamin D and corticosterone (the active murine corticosteroid, analagoue to cortisol in humans) in modulation of the nVDR expression in adipocytes.
Materials and methods
Cell culture 3T3-L1 preadipocytes were incubated at a density of 8000 cells cm À2 (10 cm 2 dish) and grown in the absence of insulin in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and antibiotics (1% penicillinstreptomycin) (adipocyte medium) at 37 1C in 5% CO 2 in air. Confluent preadipocytes were induced to differentiate with a standard differentiation medium consisting of Dulbecco's modified Eagle's medium-F10 (1:1, vol/vol) supplemented with 1% fetal bovine serum, 250 nM dexamethasone (DEXA), isobutylmethylxanthine (IBMX) (0.5 mM) and antibiotics. Preadipocytes were maintained in this differentiation medium for 3 days (unless specifically indicated) and subsequently cultured in adipocyte medium.
Cultures were re-fed every 2-3 days to allow 90% cells to reach full differentiation before chemical treatment unless specifically indicated. In some experiments, the supernatants of differentiated 3T3-L1 adipocytes were collected to evaluate the corticosterone release in the medium and at À20 1C until assayed.
Cell transfection
Small interfering RNA (siRNA)-annealed oligonucleotide duplexes for 11b-hydroxysteroid dehydrogenase I (11b-HSD I) (sequence 5 0 -3 0 sense: GGAAAUCUCUGGGAUAAUUtt; antisense: AAUUAUCCCAGAGAUUUCCtt) and negative control (Catalog no. 4611) were purchased from Ambion (Austin, TX, USA) and transfected using siPORT NeoFX (Ambion) following the manufacturer's instructions.
Total RNA extraction A total cellular RNA isolation kit (Ambion) was used to extract total RNA from cells according to the manufacturer's instruction.
Quantitative real-time PCR Adipocyte 18 s, nVDR and 11b-HSD I were quantitatively measured using a smart cycler real-time PCR system (Cepheid, Sunnyvale, CA, USA) with a TaqMan 1000 Core Reagent Kit (Applied Biosystems, Branchburg, NJ, USA). The primers and probe sets were obtained from Applied Biosystems TaqMan Assays-on-Demand Gene Expression primers and probe set collection and used according to the manufacturer's instructions. Pooled adipocyte total RNA was serial diluted in the range of 1.5625-25 ng and used to establish a standard curve; total RNA for the unknown samples were also diluted in this range. Reactions of quantitative reverse transcription-PCR for standard and unknown samples were also performed according to the instructions of Smart Cycler System (Cepheid) and TaqMan Real Time PCR Core Kit (Applied Biosystems). The mRNA quantitation for each sample was further normalized using the corresponding 18 s quantitation.
Corticosterone release assay A corticosterone ELISA kit (Assay Design, Ann Arbor, MI, USA) was used to measure corticosterone release in the medium according to the manufacturer's instruction.
Statistical analysis
Data were evaluated for statistical significance by analysis of variance, and significantly different group means were then separated by the least significant difference test by using SPSS (SPSS Inc., Chicago, IL, USA). All data presented are expressed as mean ± s.e.m.
Results
Nuclear vitamin D receptor was expressed at a very low level in 3T3-L1 preadipocytes, but differentiation using IBMX and DEXA induced a rapid 1150% increase within 3 h (Po0.001), which then declined rapidly to preadipocyte levels at differentiation day 3 and remained at this low level Role of 1a, 25-Dihydroxyvitamin D in adipocyte X Sun and MB Zemel thereafter ( Figure 1a ). To further investigate whether the expression pattern of nVDR is differentiation related, we treated the differentiated 3T3-L1 adipocytes 9 days after differentiation with the same concentration of IBMX and/or DEXA used in the differentiation medium. We found that IBMX and DEXA increased nVDR expression by 1623 and 285%, respectively (Po0.05), and the combination of IBMX and DEXA further stimulated nVDR expression by 2828% (Po0.05) ( Figure 1b) ; this indicates that increased nVDR expression is not a solely differentiation-related cellular event, as it is readily induced in mature adipocytes. 1a, 25-Dihydroxyvitamin D induced a mild but not significant increase in nVDR expression by 43% in 3 h in fully differentiated adipocytes (Figure 2a) , whereas 48 h treatment with 1a, 25-dihydroxyvitamin D induced a 685% increase (Po0.01). Interestingly, 11b-dehydrocorticosterone (the inactive murine corticosteroid, analogous to cortisone in humans), a precursor of active glucocorticoid, did not affect nVDR expression, whereas the active glucocorticoid DEXA significantly stimulated nVDR expression within 3 h (Figure 2a ). However, 48 h treatment with 11b-dehydrocorticosterone induced nVDR expression by 645% (Po0.01) ( Figure 2b) . Notably, the 11b-dehydrocorticosterone/1a, 25-dihydroxyvitamin D combination induced additional increases in nVDR expression by B60% (Po0.05) compared with either treatment alone ( Figure 2b ).
Based on these data, we hypothesized that inhibition of 11b-dehydrocorticosterone conversion to corticosterone will suppress nVDR expression. As we previously demonstrated that 1a, 25-dihydroxyvitamin D stimulates cortisol production through stimulation of 11b-HSD I expression in human adipocytes, we investigated the effects of 11b-dehydrocorticosterone and 1a, 25-dihydroxyvitamin D on nVDR expression in 11b-HSD I knockdown 3T3-L1 adipocytes using siRNA. Figure 3a shows 63% knockdown 11b-HSD I in siRNA transfected cells compared with wild-type and negative control cells. Knockdown of 11b-HSD I in adipocytes significantly reduced nVDR expression by 58% (Po0.002) (Figure 3b 
Discussion
Data from the present study indicated that nVDR is expressed at low levels in both preadipocytes and mature adipocytes; moreover, consistent with data from Hollenberg et al., 7 nVDR expression is transiently stimulated during adipogenesis. However, our data indicate that this is not specifically a differentiation event, as IBMX, DEXA, 11b-dehydrocorticosterone and 1a, 25-dihydroxyvitamin D all stimulate nVDR expression in mature adipocytes. We previously found 1a, 25-dihydroxyvitamin D to stimulate 11b-HSD I expression and thereby promote the conversion of the glucocorticoid precursor cortisone to cortisol. 8 Our present data demonstrate that the synthetic active corticosteroid DEXA stimulates nVDR expression. Accordingly, we 
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propose that this represents a positive feedback loop, with 1a, 25-dihydroxyvitamin D stimulating corticosterone production and corticosterone stimulating nVDR expression. In support of this concept, long-term treatment of adipocytes with 11b-dehydrocorticosterone or a 11b-dehydrocorticosterone/1a, 25-dihydroxyvitamin D combination stimulated nVDR expression, whereas knockdown of 11b-HSD I using siRNA suppressed nVDR expression and attenuated 1a, 25-dihydroxyvitamin D-induced nVDR expression. However, 1a, 25-dihydroxyvitamin D still stimulated the corticosterone production in 11b-HSD I knockdown adipocytes, indicating that 1a, 25-dihydroxyvitamin D may regulate corticosterone release through additional mechanisms. Short-term treatment with reagents regulating calcium influx on adipocytes such as calcium channel depolarizer KCl, L-type calcium-channel agonist BAYK8644, 1a, 25-dihydroxyvitamin D and 1a, 25-dihydroxyvitamin D membrane receptor, 1, 25D 3 -MARRS agonist lumisterol increased corticosterone release significantly, whereas antagonism of 1, 25D 3 -MARRS by 1 b, 25-dihydroxyvitamin D exerted the opposite effect, suggesting that 1a, 25-dihydroxyvitamin D also regulates corticosterone release, and this effect appears to be calcium dependent and nVDR independent.
We previously demonstrated an anti-obesity effect of high dietary calcium, which is mediated, in part, by suppression of 1a, 25- Role of 1a, 25-Dihydroxyvitamin D in adipocyte X Sun and MB Zemel vitamin D via a putative membrane vitamin receptor, which later was identified as the 1, 25D 3 -MARRS, 20 in modulating
Polymorphisms in the nVDR are associated with obesity susceptibility in humans, 21, 22 and several lines of evidence demonstrate alterations in the vitamin D-endocrine system in obese humans. 23, 24 We have demonstrated that 1a, 25-dihydroxyvitamin D suppresses uncoupling protein 2 expression in human adipocytes, 6 and this effect appears to be mediated by the adipocyte nVDR, as 1b, 25-dihydroxyvitamin D was unable to block this effect, whereas nVDR knockout successfully inhibited it. Suppression of 1a, 25-dihydroxyvitamin D by feeding high calcium diets to mice results in increased adipose tissue uncoupling protein 2 and skeletal muscle uncoupling protein 3 expression. 25 An association of nVDR with adipogenesis in 3T3-L1 adipocytes has been described previously. Hollenberg et al. 7 demonstrated a complex role of nVDR in modulating adipogenesis, as liganded nVDR with 1a, 25-dihydroxyvitamin D inhibited adipogenesis, whereas unoccupied nVDR was required for adipogenesis. Their data also demonstrated an expression pattern of nVDR during adipogenesis similar to our observations. Consistent with this, Rayalam et al. 26 recently reported that 1a, 25-dihydroxyvitamin D inhibits adipogenesis but maintains nVDR mRNA and protein production, which otherwise declines rapidly throughout adipogenesis; their data further suggest that the effects of 1a, 25-dihydroxyvitamin D in adipocytes may be mediated, in part, via apoptosis. On the other hand, although Kern et al. Role of 1a, 25-Dihydroxyvitamin D in adipocyte X Sun and MB Zemel promote adipogenesis and decrease nVDR density. However, these studies focused only on adipogenesis and neither evaluated the effects of 1a, 25-dihydroxyvitamin D or DEXA in mature adipocytes. In contrast, our data demonstrate that nVDR expression in mature adipocytes is subject to the regulation by both agents, possibly explaining the metabolic effect of nVDR ligands.
Local adipose tissue glucocorticoid levels and intracellular glucocorticoid availability are controlled by the activity of 11b-HSD I, generating active cortisol from cortisone. 28 Overexpression of 11b-HSD I specifically in white adipose tissue of transgenic mice recapitulates features of the metabolic syndrome, including central obesity, hypertension, dyslipidemia and insulin resistance, suggesting that tissue-specific dysregulation of glucocorticoid metabolism may promote expansion of adipose tissue stores. 29, 30 We have recently reported that 1a, 25-dihydroxyvitamin D increases both 11b-HSD I expression, and cortisol release in cultured human adipocytes demonstrated a key role of 1a, 25-dihydroxyvitamin D in modulating local glucocorticoid production in adipose tissue. 8 These data suggest an interesting positive feedback regulation of glucocorticoid on 1a, 25-dihydroxyvitamin D as described in Figure 5 . We propose that the increased corticosterone, which results from liganded adipocyte nVDR stimulation of 11b-HSD I, upregulates nVDR expression, resulting in further potential binding of 1a, 25-dihydroxyvitamin D by the nVDR and consequent further stimulation of active glucocorticoid generation. However, these conclusions have been derived from 3T3-L1 adipocytes and have not yet been confirmed in primary adipocytes. In addition, our conclusions are limited by the exclusive focus on receptor expression without corresponding measurement of protein content. Interestingly, 1a, 25-dihydroxyvitamin D and DEXA have also been demonstrated to modulate 1a, 25-dihydroxyvitamin D by increasing expression of the catabolic enzyme 24-OHase and by inhibiting expression of the anabolic enzyme 1aOHase. 31, 32 Although it is not clear whether the nVDR promoter contains a region that also confers glucocorticoid responses, potential candidates would include the most closely related nuclear receptors, such as FXR (farnesoid Â receptor) 32 and SXR/PXR (steroid xenobiotic receptor/pregnane Â receptor). 33 Notably, 1a, 25-dihydroxyvitamin D also exerts an additional effect on corticosterone release, and this effect appears to be independent of the nVDR and is instead mediated by intracellular calcium signalling.
In summary, we have demonstrated a direct role for both 1a, 25-dihydroxyvitamin D and glucocorticoid in modulating nVDR mRNA expression in mature adipocytes. As 1a, 25-dihydroxyvitamin D binding to nVDR also increases active glucocorticoid production, these data indicate an interesting positive feedback loop in which 1a, 25-dihydroxyvitamin D stimulates glucocorticoid production, and glucocorticoid increases nVDR, thereby potentially further increasing glucocorticoid production ( Figure 5 ). Role of 1a, 25-Dihydroxyvitamin D in adipocyte X Sun and MB Zemel
